Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users (original) (raw)

Changing trends in peptic ulcer disease: the rise of NSAID-induced and fall of H pylori-induced ulcers

Gut, 2011

Helicobacter pylori infection and the use of NSAIDs

2000

The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010

Munir Pirmohamed

Alimentary Pharmacology & Therapeutics, 2012

View PDFchevron_right

Specifics of Helicobacter pylori Infection/NSAID Effects in the Elderly

Mladen Davidovic

View PDFchevron_right

Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users

Xavier Calvet

Alimentary Pharmacology and Therapeutics, 2000

View PDFchevron_right

The Association of Helicobacter Pylori Infection and Non-Steroidal Anti-Inflammatory Drugs in Peptic-Ulcer Disease

Sergio Zepeda-gomez

American Journal of Gastroenterology

View PDFchevron_right

Helicobacter pylori infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta‐analysis

Neville Yeomans

The Medical Journal of Australia, 2018

View PDFchevron_right

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

Javier Fuentes

Gastroenterology, 2000

View PDFchevron_right

Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

Xavier Calvet

Alimentary Pharmacology and Therapeutics, 2005

View PDFchevron_right

Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial

Harald Vonkeman

Helicobacter, 2007

View PDFchevron_right

Ulcer risk factors: Interactions between Helicobacter pylori infection, nonsteroidal use, and age

Timothy Schubert

The American Journal of Medicine, 1993

View PDFchevron_right

Outcome of Peptic Ulcer Bleeding, Nonsteroidal Anti-inflammatory Drug Use, and Infection

Erik Rauws

Clinical Gastroenterology and Hepatology, 2005

View PDFchevron_right

Gastropathy of old age: Helicobacter pylori infection or NSAID use

Dragoslav Milosevic, Mladen Davidovic

MedGenMed : Medscape general medicine, 2004

View PDFchevron_right

Role of Helicobacter pylori Infection in Gastroduodenal Damage in Patients Starting NSAID Therapy: 4 Months Follow-Up Study

Tamara Alempijevic

Digestive Diseases and Sciences, 2010

View PDFchevron_right

The Role ofHelicobacter pyloriand NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer

Cem Sezer

Gastroenterology Research and Practice, 2012

View PDFchevron_right

Comparative study between H. Pylori induced and NSAIDs induced peptic ulcer

Krishnendhu Ajayakumar

Journal of Current Medical Research and Opinion, 2021

View PDFchevron_right

Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial

Wilfred Weinstein

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right

What effect does Helicobacter pylori infection have on the risk of peptic ulceration in patients receiving NSAIDs for rheumatoid arthritis?

Clive Kelly

European Journal of Internal Medicine, 2002

View PDFchevron_right

Role of Helicobacter Pylori Infection and Nonsteroidal Anti-Inflammatory Drug Use in Bleeding Peptic Ulcers

Zainab Irshad

Pakistan Journal of Health Sciences

View PDFchevron_right

Frequency of NSAID induced peptic ulcer disease

Javed Yakoob

JPMA. The Journal of the Pakistan Medical Association, 2006

View PDFchevron_right

Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin

Jiro Watari

Journal of Gastroenterology, 2012

View PDFchevron_right

Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis

Neville Yeomans

Journal of Gastroenterology and Hepatology, 2018

View PDFchevron_right

Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects

Marilisa Franceschi

Alimentary Pharmacology & Therapeutics, 2000

View PDFchevron_right

Assessment of Helicobacter pylori eradication in patients on NSAID treatment

Matthijs Janssen

BMC Gastroenterology, 2012

View PDFchevron_right

Comparison of demographic, clinical and endoscopic characteristics of peptic ulcer due to Helicobacter Pylori and NSAIDs

Caspian Journal of Internal Medicine (CJIM)

Caspian Journal of Internal Medicine, 2010

View PDFchevron_right

Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate

Rupert Leong

The American Journal of Medicine, 2001

View PDFchevron_right

Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease

Seyed Hashemi, Mohammad Shojaie

Alimentary Pharmacology and Therapeutics, 2001

View PDFchevron_right

Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study

Yoshiro Kawahara

Gut and liver, 2015

View PDFchevron_right

Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care

Elisa Morini

Internal and Emergency Medicine

View PDFchevron_right

Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users (original) (raw)

Related papers